Neuroinfections caused by herpesviruses, primarily HHV-1, pose a significant challenge for modern medicine due to the scarcity of therapeutic substances in the pharmaceutical industry. Furthermore, HHV-1 infection has been linked to neurodegenerative processes like Alzheimer's disease, justifying the search for new effective treatments. The advancement of nanotechnology opens up new avenues for treating neuroinflammation. Gold and silver nanoparticles are becoming increasingly popular, and the number of clinical trials involving metallic nanoparticles is growing all the time. The research on gold and silver nanoparticles and their potential use in the treatment of herpesvirus neuroinfection is reviewed in this paper.
HTML PDFShare this article
Journal of Infectious Diseases and Medicine received 59 citations as per Google Scholar report
